Eastman Chemical pullback post Q1 results unwarranted, says Deutsche Bank Deutsche Bank views the 3% pullback in shares of Eastman Chemical following the company's Q1 results as unwarranted. Deutsche points out Eastman reaffirmed its 2014 guidance despite "severe headwinds" from higher propane prices. The firm finds the stock's valuation compelling and it keeps a Buy rating on the name with an increased price target of $100.
Eastman Chemical remains a top pick, says UBS UBS said Eastman Chemical remains a top pick as it continues to transform its portfolio mix. The firm expects acquired businesses to be accretive and does not believe its multiple reflects the company's transformation via M&A. UBS reiterates its Buy rating and raised its price target to $92 from $90 on Eastman Chemical shares.